Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Utpal Das

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Biochemical and Biophysical Research Communications|August 21, 2007
Interface peptide of Alzheimer's amyloid beta: application in purificationUtpal Das, Gururao Hariprasad, Santosh Pasha, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|March 12, 2009
A single mutation induces molten globule formation and a drastic destabilization of wild-type cytochrome c at pH 6.0Md Khurshid Alam Khan, Utpal Das, Md Hamidur Rahaman, et al.
Chirality|May 17, 2012
Enantioselective organocatalytic Michael addition of ketones to alkylidene malonatesSiang-En Syu, Chan-Hui Huang, Ko-Wei Chen, et al.
Molecular Biology of the Cell|December 9, 2020
Cholesterol-lowering drugs reduce APP processing to Aβ by inducing APP dimerizationVanessa F Langness, Rik van der Kant, Utpal Das, et al.
Dalton Transactions (Cambridge, England : 2003)|July 26, 2021
GSH-resistant and highly cytoselective ruthenium(II)-<i>p</i>-cymene-(imidazo[4,5-<i>f</i>][1,10]phenanthrolin-2-yl)phenol complexes as potential anticancer agentsBinoy Kar, Utpal Das, Sourav De, et al.
Biochemical and Biophysical Research Communications|July 21, 2007
Surface plasmon resonance studies and biochemical evaluation of a potent peptide inhibitor against cyclooxygenase-2 as an anti-inflammatory agentRishi K Somvanshi, Ashwini Kumar, Shashi Kant, et al.
Journal of Medicinal Chemistry|December 7, 2025
Turning the Spotlight Away from PDT: Chemodynamic Dominance of 2-(2-Bromopyridin-4-yl)-1<i>H</i>-imidazo[4,5-<i>f</i>][1,10]phenanthroline Based Ru(II)/Ir(III)/Re(I) Complexes against MDA-MB-231Rishav Das, Shanooja Shanavas, Utpal Das, et al.
NPJ Parkinson'S Disease|May 12, 2026
Preformed fibrils of α-synuclein rapidly activate LRRK2 on early endosomes, driving Rab5 phosphorylation and disrupting endolysosomal and synaptic functionXinxin Zuo, Zeyu Chen, Xu-Qiao Chen, et al.
ACS Omega|April 10, 2023
G2/M-Phase-Inhibitory Mitochondrial-Depolarizing Re(I)/Ru(II)/Ir(III)-2,2'-Bipyrimidine-Based Heterobimetallic Luminescent Complexes: An Assessment of In Vitro Antiproliferative Activity and Bioimaging for Targeted Therapy toward Human TNBC CellsNilmadhab Roy, Shanooja Shanavas, Binoy Kar, et al.
The Journal of Organic Chemistry|June 20, 2012
Stereoselective synthesis of o-bromo (or iodo)aryl P-chirogenic phosphines based on aryne chemistryJérôme Bayardon, Hugo Laureano, Vincent Diemer, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Biochemical and Biophysical Research Communications|August 21, 2007
Interface peptide of Alzheimer's amyloid beta: application in purificationUtpal Das, Gururao Hariprasad, Santosh Pasha, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|March 12, 2009
A single mutation induces molten globule formation and a drastic destabilization of wild-type cytochrome c at pH 6.0Md Khurshid Alam Khan, Utpal Das, Md Hamidur Rahaman, et al.
Chirality|May 17, 2012
Enantioselective organocatalytic Michael addition of ketones to alkylidene malonatesSiang-En Syu, Chan-Hui Huang, Ko-Wei Chen, et al.
Molecular Biology of the Cell|December 9, 2020
Cholesterol-lowering drugs reduce APP processing to Aβ by inducing APP dimerizationVanessa F Langness, Rik van der Kant, Utpal Das, et al.
Dalton Transactions (Cambridge, England : 2003)|July 26, 2021
GSH-resistant and highly cytoselective ruthenium(II)-<i>p</i>-cymene-(imidazo[4,5-<i>f</i>][1,10]phenanthrolin-2-yl)phenol complexes as potential anticancer agentsBinoy Kar, Utpal Das, Sourav De, et al.
Biochemical and Biophysical Research Communications|July 21, 2007
Surface plasmon resonance studies and biochemical evaluation of a potent peptide inhibitor against cyclooxygenase-2 as an anti-inflammatory agentRishi K Somvanshi, Ashwini Kumar, Shashi Kant, et al.
Journal of Medicinal Chemistry|December 7, 2025
Turning the Spotlight Away from PDT: Chemodynamic Dominance of 2-(2-Bromopyridin-4-yl)-1<i>H</i>-imidazo[4,5-<i>f</i>][1,10]phenanthroline Based Ru(II)/Ir(III)/Re(I) Complexes against MDA-MB-231Rishav Das, Shanooja Shanavas, Utpal Das, et al.
NPJ Parkinson'S Disease|May 12, 2026
Preformed fibrils of α-synuclein rapidly activate LRRK2 on early endosomes, driving Rab5 phosphorylation and disrupting endolysosomal and synaptic functionXinxin Zuo, Zeyu Chen, Xu-Qiao Chen, et al.
ACS Omega|April 10, 2023
G2/M-Phase-Inhibitory Mitochondrial-Depolarizing Re(I)/Ru(II)/Ir(III)-2,2'-Bipyrimidine-Based Heterobimetallic Luminescent Complexes: An Assessment of In Vitro Antiproliferative Activity and Bioimaging for Targeted Therapy toward Human TNBC CellsNilmadhab Roy, Shanooja Shanavas, Binoy Kar, et al.
The Journal of Organic Chemistry|June 20, 2012
Stereoselective synthesis of o-bromo (or iodo)aryl P-chirogenic phosphines based on aryne chemistryJérôme Bayardon, Hugo Laureano, Vincent Diemer, et al.
Pageof 8